Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Cash flows from operating activities:
Net income (loss)	$ (6,911,752)	$ 9,219,037
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Amortization (accretion) of investments	(92,439)	(48,692)
Realized investment gains, net	(716,300)	(4,780,149)
Change in fair value of equity securities	8,645,474	(8,154,629)
Unrealized trading (gains) losses included in income	0	470
Realized investment gains (losses), net	0	2,516
Amortization of cost of insurance acquired	165,314	172,087
Depreciation and depletion	174,692	327,883
Stock-based compensation	674,390	486,797
Charges for mortality and administration of universal life and annuity products	(1,448,416)	(1,500,108)
Interest credited to account balances	921,074	948,325
Change in accrued investment income	310,385	286,260
Change in reinsurance receivables	368,886	(21,913)
Change in policy liabilities and accruals	(1,431,856)	(1,067,549)
Change in income taxes receivable (payable)	(122,733)	1,049,842
Change in other assets and liabilities, net	1,459,816	904,101
Net cash provided by (used in) operating activities	1,996,535	(2,175,722)
Proceeds from investments sold and matured:
Fixed maturities available for sale	20,833	6,021,700
Equity securities	958,779	2,517,691
Trading securities	0	9,501
Mortgage loans	984,587	281,974
Real estate	2,046,096	6,573,943
Notes receivable	66,622	3,844,443
Policy loans	280,253	275,914
Short-term investments	9,740,815	0
Total proceeds from investments sold and matured	14,097,985	19,525,166
Cost of investments acquired:
Fixed maturities available for sale	0	(50,000)
Equity securities	(1,393,053)	(3,913,832)
Trading securities	0	(8,311)
Mortgage loans	0	(1,546,165)
Real estate	(1,375,010)	(1,680,959)
Notes receivable	(1,478,100)	(2,060,657)
Policy loans	(208,423)	(207,030)
Short-term investments	(9,701,297)	0
Total cost of investments acquired	(14,155,883)	(9,466,954)
Net cash provided by (used in) investing activities	(57,898)	10,058,212
Cash flows from financing activities:
Policyholder contract deposits	1,110,855	1,278,889
Policyholder contract withdrawals	(956,744)	(1,416,469)
Payments of principal on notes payable/line of credit	(19,000,000)	(14,000,000)
Purchase of treasury stock	(100,228)	(267,433)
Non controlling contributions (distributions) of consolidated subsidiary	0	(3)
Net cash used in financing activities	(18,946,117)	(14,405,016)
Net increase (decrease) in cash and cash equivalents	(17,007,480)	(6,522,526)
Cash and cash equivalents at beginning of period	45,290,385	30,787,278
Cash and cash equivalents at end of period	$ 28,282,905	$ 24,264,752